Psoriasis can involve sensitive areas like the face, palms, armpits, groin, genitals, and underneath the breasts. Here’s how ...

Roflumilast foam, 0.3%, improved psoriasis symptoms on the scalp and body in people 12 years and older. According to researchers, the formulation could help improve treatment adherence among these ...

Eczema and psoriasis come with similar symptoms and therefore can be easy to confuse. Here's how to differentiate the two.

The FDA has approved roflumilast foam 0.3%, a PDE-4 inhibitor, as a once-daily topical treatment for plaque psoriasis in adults and adolescents aged 12 years and older. The drug met both of the ...

Credit: Arcutis. The approval was supported by data from 2 randomized, double-blind, vehicle-controlled trials that included 736 patients aged 12 years and older with mild to severe plaque psoriasis ...

Arcutis Biotherapeutics has received FDA approval for ZORYVE (roflumilast) topical foam 0.3%, which is now available for treating plaque psoriasis on the scalp and body in patients aged 12 and older.

Total Body Wellness Day underscores the importance of connection—whether it’s partnering with health care providers, advocating for personal health, or finding support in relationships. NPF offers ...

A slightly more premium option, and one that includes the same colloidal oatmeal as the Aveeno cream above, Dr Armstrong ...

A woman was hurt when her friend asked if she'd wear body paint to cover up her psoriasis while acting as the maid of honor at her wedding While the bride initially told her it was so that she'd have ...

Once-daily, steroid-free roflumilast foam 0.3% demonstrated significant improvements in both scalp and body psoriasis across all efficacy endpoints compared to vehicle New data highlights a ...